Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder
Clinical trial NCT05536414 · COMPLETED
Trial details
- NCT number
- NCT05536414
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-12
- Primary completion
- 2025-05-16
- Enrollment
- 337
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.